170 related articles for article (PubMed ID: 32057312)
1. Modeling Down syndrome in cells: From stem cells to organoids.
Gough G; O'Brien NL; Alic I; Goh PA; Yeap YJ; Groet J; Nizetic D; Murray A
Prog Brain Res; 2020; 251():55-90. PubMed ID: 32057312
[TBL] [Abstract][Full Text] [Related]
2. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.
Çağlayan ES
Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462
[TBL] [Abstract][Full Text] [Related]
3. DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.
Tang XY; Xu L; Wang J; Hong Y; Wang Y; Zhu Q; Wang D; Zhang XY; Liu CY; Fang KH; Han X; Wang S; Wang X; Xu M; Bhattacharyya A; Guo X; Lin M; Liu Y
J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33945512
[TBL] [Abstract][Full Text] [Related]
4. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
Hohmann SS; Ilieva M; Michel TM
Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
[TBL] [Abstract][Full Text] [Related]
5. Generation of Urine-Derived Induced Pluripotent Stem Cells and Cerebral Organoids for Modeling Down Syndrome.
Teles E Silva AL; Yokota BY; Sertié AL; Zampieri BL
Stem Cell Rev Rep; 2023 May; 19(4):1116-1123. PubMed ID: 36652145
[TBL] [Abstract][Full Text] [Related]
6. OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.
Xu R; Brawner AT; Li S; Liu JJ; Kim H; Xue H; Pang ZP; Kim WY; Hart RP; Liu Y; Jiang P
Cell Stem Cell; 2019 Jun; 24(6):908-926.e8. PubMed ID: 31130512
[TBL] [Abstract][Full Text] [Related]
7. Applications of kidney organoids derived from human pluripotent stem cells.
Kim YK; Nam SA; Yang CW
Korean J Intern Med; 2018 Jul; 33(4):649-659. PubMed ID: 29961307
[TBL] [Abstract][Full Text] [Related]
8. Abnormal mitochondria in Down syndrome iPSC-derived GABAergic interneurons and organoids.
Xu L; Huo HQ; Lu KQ; Tang XY; Hong Y; Han X; Fu ZX; Fang KH; Xu M; Guo X; Liu Y
Biochim Biophys Acta Mol Basis Dis; 2022 Jun; 1868(6):166388. PubMed ID: 35301086
[TBL] [Abstract][Full Text] [Related]
9. Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis.
Gomez-Giro G; Arias-Fuenzalida J; Jarazo J; Zeuschner D; Ali M; Possemis N; Bolognin S; Halder R; Jäger C; Kuper WFE; van Hasselt PM; Zaehres H; Del Sol A; van der Putten H; Schöler HR; Schwamborn JC
Acta Neuropathol Commun; 2019 Dec; 7(1):222. PubMed ID: 31888773
[TBL] [Abstract][Full Text] [Related]
10. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
[TBL] [Abstract][Full Text] [Related]
11. Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.
Murray A; Letourneau A; Canzonetta C; Stathaki E; Gimelli S; Sloan-Bena F; Abrehart R; Goh P; Lim S; Baldo C; Dagna-Bricarelli F; Hannan S; Mortensen M; Ballard D; Syndercombe Court D; Fusaki N; Hasegawa M; Smart TG; Bishop C; Antonarakis SE; Groet J; Nizetic D
Stem Cells; 2015 Jun; 33(6):2077-84. PubMed ID: 25694335
[TBL] [Abstract][Full Text] [Related]
12. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
13. An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model.
Mensah A; Mulligan C; Linehan J; Ruf S; O'Doherty A; Grygalewicz B; Shipley J; Groet J; Tybulewicz V; Fisher E; Brandner S; Nizetic D
BMC Dev Biol; 2007 Nov; 7():131. PubMed ID: 18047653
[TBL] [Abstract][Full Text] [Related]
14. Modeling amyloid beta and tau pathology in human cerebral organoids.
Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
[TBL] [Abstract][Full Text] [Related]
15. Psychiatry in a Dish: Stem Cells and Brain Organoids Modeling Autism Spectrum Disorders.
Ilieva M; Fex Svenningsen Å; Thorsen M; Michel TM
Biol Psychiatry; 2018 Apr; 83(7):558-568. PubMed ID: 29295738
[TBL] [Abstract][Full Text] [Related]
16. Reporter-based fate mapping in human kidney organoids confirms nephron lineage relationships and reveals synchronous nephron formation.
Howden SE; Vanslambrouck JM; Wilson SB; Tan KS; Little MH
EMBO Rep; 2019 Apr; 20(4):. PubMed ID: 30858339
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
González F
Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
[TBL] [Abstract][Full Text] [Related]
18. Culture Systems of Dissociated Mouse and Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells Purified by Two-Step Immunopanning.
Kobayashi W; Onishi A; Tu HY; Takihara Y; Matsumura M; Tsujimoto K; Inatani M; Nakazawa T; Takahashi M
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):776-787. PubMed ID: 29392326
[TBL] [Abstract][Full Text] [Related]
19. Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology.
Kim J; Koo BK; Yoon KJ
Viruses; 2019 Jan; 11(2):. PubMed ID: 30704043
[TBL] [Abstract][Full Text] [Related]
20. Studying Kidney Disease Using Tissue and Genome Engineering in Human Pluripotent Stem Cells.
Garreta E; González F; Montserrat N
Nephron; 2018; 138(1):48-59. PubMed ID: 28988229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
